Equities researchers at Brookline Capital Management assumed coverage on shares of Forte Biosciences (NASDAQ:FBRX – Get Free Report) in a report issued on Thursday, Benzinga reports. The firm set a “buy” rating and a $4.00 price target on the stock. Brookline Capital Management also issued estimates for Forte Biosciences’ Q2 2024 earnings at ($0.16) EPS, […]
Anixa Biosciences, Inc. (NASDAQ:ANIX – Get Free Report) was the target of a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 554,300 shares, a drop of 12.3% from the April 30th total of 632,100 shares. Approximately 1.8% of the shares of the company are […]
Shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX – Get Free Report) have been given a consensus rating of “Moderate Buy” by the nine ratings firms that are covering the company, MarketBeat reports. Four analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12-month price […]
Pulse Biosciences (NASDAQ:PLSE) Sets New 12-Month High at $13.74 modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
Aptose Biosciences (TSE:APS) Hits New 1-Year Low at $1.36 dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.